Eli Lilly To Lower Price of Zepbound Vials, GLP-1 Shortage Is Over
Feb. 25, 2025 Eli Lilly said today that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from cheap, compounded copies of weight loss medications. Zepbound was originally sold in injectable pens at […]
Eli Lilly To Lower Price of Zepbound Vials, GLP-1 Shortage Is Over Read More »